These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31164199)

  • 1. An App knock-in mouse inducing the formation of a toxic conformer of Aβ as a model for evaluating only oligomer-induced cognitive decline in Alzheimer's disease.
    Izuo N; Murakami K; Fujihara Y; Maeda M; Saito T; Saido TC; Irie K; Shimizu T
    Biochem Biophys Res Commun; 2019 Jul; 515(3):462-467. PubMed ID: 31164199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer's Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression.
    Maki T; Sawahata M; Akutsu I; Amaike S; Hiramatsu G; Uta D; Izuo N; Shimizu T; Irie K; Kume T
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of a Novel Alzheimer's Disease Model Based on the Theory of the Toxic-conformer of Amyloid β].
    Izuo N; Shimizu T; Murakami K; Irie K
    Yakugaku Zasshi; 2021; 141(6):843-849. PubMed ID: 34078792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in open field activity in the absence of memory deficits in the App
    Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
    Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP
    Mehla J; Lacoursiere SG; Lapointe V; McNaughton BL; Sutherland RJ; McDonald RJ; Mohajerani MH
    Neurobiol Aging; 2019 Mar; 75():25-37. PubMed ID: 30508733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App
    Andersson E; Schultz N; Saito T; Saido TC; Blennow K; Gouras GK; Zetterberg H; Hansson O
    Alzheimers Res Ther; 2023 Mar; 15(1):64. PubMed ID: 36964585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.
    Armstrong P; Güngör H; Anongjanya P; Tweedy C; Parkin E; Johnston J; Carr IM; Dawson N; Clapcote SJ
    Neuropsychopharmacology; 2024 Sep; 49(10):1559-1568. PubMed ID: 38521860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
    Jiang R; Smailovic U; Haytural H; Tijms BM; Li H; Haret RM; Shevchenko G; Chen G; Abelein A; Gobom J; Frykman S; Sekiguchi M; Fujioka R; Watamura N; Sasaguri H; Nyström S; Hammarström P; Saido TC; Jelic V; Syvänen S; Zetterberg H; Winblad B; Bergquist J; Visser PJ; Nilsson P
    Acta Neuropathol Commun; 2022 Jul; 10(1):96. PubMed ID: 35787306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and
    Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P
    ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP
    Latif-Hernandez A; Shah D; Craessaerts K; Saido T; Saito T; De Strooper B; Van der Linden A; D'Hooge R
    Behav Brain Res; 2019 May; 364():431-441. PubMed ID: 29158112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Touchscreen-based location discrimination and paired associate learning tasks detect cognitive impairment at an early stage in an App knock-in mouse model of Alzheimer's disease.
    Saifullah MAB; Komine O; Dong Y; Fukumoto K; Sobue A; Endo F; Saito T; Saido TC; Yamanaka K; Mizoguchi H
    Mol Brain; 2020 Nov; 13(1):147. PubMed ID: 33183323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App
    Arroyo-García LE; Isla AG; Andrade-Talavera Y; Balleza-Tapia H; Loera-Valencia R; Alvarez-Jimenez L; Pizzirusso G; Tambaro S; Nilsson P; Fisahn A
    Mol Psychiatry; 2021 Oct; 26(10):5557-5567. PubMed ID: 34385602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. App
    Hamaguchi T; Tsutsui-Kimura I; Mimura M; Saito T; Saido TC; Tanaka KF
    Neurochem Int; 2019 Oct; 129():104470. PubMed ID: 31102607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App
    Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Hyperhomocysteinemia and Different Dietary Interventions on Cognitive Performance in a Knock-in Mouse Model for Alzheimer's Disease.
    Nieraad H; de Bruin N; Arne O; Hofmann MCJ; Schmidt M; Saito T; Saido TC; Gurke R; Schmidt D; Till U; Parnham MJ; Geisslinger G
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.